Folic acid food fortification is associated with a decline in neuroblastoma
The DOI matches its Crossref record.
Abstract
BACKGROUND: Neuroblastoma, an embryonic tumor, is the second most common pediatric tumor and is the most prevalent extracranial solid tumor in children. Results of previous studies have suggested that maternal vitamin intake may decrease the risk of several childhood cancers. In January 1997, Canada began fortifying flour with folic acid for the prevention of neural tube defects. The effect of folic acid fortification on the rate of neuroblastoma in offspring is not known. METHODS: We investigated the rates of neuroblastoma (<1 year), acute lymphoblastic leukemia, and hepatoblastoma registered by the Pediatric Oncology Group of Ontario, which captures 95% of all pediatric cancers in Ontario, before and after the introduction of folate fortification. RESULTS: An interventional time series analysis showed that the incidence of neuroblastoma declined from 1.57 cases per 10,000 births before to 0.62 case per 10,000 births after folic acid fortification (P <.0001). The crude incidence rate ratio (0.40; 95% confidence interval, 0.25-0.64) remained significant after adjustment for both age and disease stage at diagnosis (adjusted incidence rate ratio, 0.38; 95% confidence interval, 0.23-0.62). In contrast, there was no significant change in the rate of infant acute lymphoblastic leukemia (incidence rate ratio, 0.97; 95% confidence interval, 0.41-2.27) or hepatoblastoma (incidence rate ratio, 0.81; 95% confidence interval, 0.35-1.89). CONCLUSIONS: Folic acid fortification was associated with a 60% reduction in neuroblastoma but was not associated with any change in the rate of infant acute lymphoblastic leukemia or hepatoblastoma. Further investigation is needed into the role of metabolism in the formation and prevention of neuroblastoma and other embryonically determined cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Will mandatory folic acid fortification prevent or promote cancer?
Kim, Y.-I. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1123 · Cited by 332
Folic acid: a public-health challenge
Eichholzer, M., Tönz, O., & Zimmermann, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68582-6 · Cited by 325
Molloy, A. M., Kirke, P. N., Brody, L. C., Scott, J. M., & Mills, J. L. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s114 · Cited by 308
“[66] noted a marked decline in the prevalence of neuroblastoma in children after the implementation of folic acid fortification in the United States, but this needs to be confirmed in other studies.”
ResultTrends in blood folate and vitamin B-12 concentrations in the United States, 1988–2004
Pfeiffer, C. M., Johnson, C. L., Jain, R. B., Yetley, E. A., Picciano, M. F., Rader, J. I., Fisher, K. D., Mulinare, J., & Osterloh, J. D. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.718 · Cited by 306
Childhood Cancer Incidence Trends in Association With US Folic Acid Fortification (1986–2008)
Linabery, A. M., Johnson, K. J., & Ross, J. A. (2012) · Pediatrics · doi:10.1542/peds.2011-3418 · Cited by 51
Metadata
- Authors
- French, A.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2003-09
- Volume
- 74
- Issue
- 3
- Pages
- 288-294
- ISSN
- 0009-9236 (ISSN-L)
- OpenAlex
- W1999064448
- Cited by
- 154
- References
- 0
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Folic acid food fortification is associated with a decline in neuroblastoma. https://app.cochat.ai/papers/10.1016/s0009-9236(03)00200-5
- The paper
- French, A. (2003). Folic acid food fortification is associated with a decline in neuroblastoma. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(03)00200-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.